跳至主要内容
临床试验/NCT00173901
NCT00173901Unknown4 期

Adverse Drug Reactions of Different Brands of Ceftazidime Injection

National Taiwan University Hospital2 个研究点 分布在 1 个国家目标入组 536 人开始时间: 2001年3月最近更新:
适应症
相关药物

试验速览

阶段
4 期
入组人数
536
试验地点
2
主要终点
The adverse drug reactions of ceftazidime

研究概览

简要总结

The purpose of this study is to understand whether generic ceftazidime causes different adverse drug reaction incidence from the brand drug.

详细描述

Ceftazidime is a third generation cephalosporins that should be reserved for severe bacterial infections. Substitution of the brand ceftazidime with a generic ceftazidime raised some concerns.

The purpose of this study is to understand whether generic ceftazidime causes different adverse drug reaction incidence from the brand drug.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single

入排标准

年龄范围
1 Year 至 95 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients in surgical intensive care unit who require ceftazidime treatment

排除标准

  • less than 1 year old

结局指标

主要结局

The adverse drug reactions of ceftazidime

次要结局

  • The effectiveness of ceftazidime

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验